Papers
6
Total Citations
210
H-Index
5
About
Dr. Michelle Chen is a leading surgeon-scientist whose research focuses on advancing minimally invasive robotic surgery for head and neck cancers, particularly oropharyngeal and tongue base malignancies. Her seminal 2014 population-level analysis of transoral robotic surgery (TORS), cited over 100 times, established baseline demographic, clinical, and pathologic characteristics of patients undergoing TORS and demonstrated its safety advantages over nonrobotic approaches—including improved margin status and reduced unplanned readmissions. Dr. Chen has been at the forefront of surgical innovation, notably pioneering the application of a next-generation, flexible single-port robotic system for tongue base resection in a 2017 cadaveric study, which showed enhanced dissection capabilities compared to traditional multiport systems. Her comprehensive analyses of complications and morbidity associated with robotic head and neck surgery, including a 2016 review of FDA device data, have been instrumental in defining safety profiles and failure criteria for these procedures. More recently, her 2022 work on the value of minimally invasive surgery using novel datasets underscores her commitment to evidence-based surgical practice. With over 200 cumulative citations, Dr. Chen’s contributions are shaping the future of robotic head and neck surgery.
Research Focus
Key Achievements
Top Papers
- 1Transoral Robotic Surgery: A Population‐Level Analysis103 citations · 2014
- 2
- 3
- 4Complications of Transoral Robotic Surgery27 citations · 2020
- 5Morbidity and Mortality Associated With Robotic Head and Neck Surgery16 citations · 2016
- 6Developing failure criteria for laceration injury of dermal tissue2 citations · 2023